Aberdeen Group plc Grows Stock Holdings in Molina Healthcare, Inc $MOH

Aberdeen Group plc lifted its holdings in Molina Healthcare, Inc (NYSE:MOH) by 109.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 135,566 shares of the company’s stock after acquiring an additional 70,840 shares during the quarter. Aberdeen Group plc owned 0.25% of Molina Healthcare worth $26,157,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in MOH. Invesco Ltd. grew its position in Molina Healthcare by 25.9% during the 2nd quarter. Invesco Ltd. now owns 1,601,574 shares of the company’s stock worth $477,109,000 after purchasing an additional 329,759 shares during the period. AQR Capital Management LLC boosted its stake in shares of Molina Healthcare by 4.6% in the second quarter. AQR Capital Management LLC now owns 925,672 shares of the company’s stock worth $273,096,000 after buying an additional 40,714 shares during the last quarter. Norges Bank purchased a new stake in shares of Molina Healthcare in the second quarter worth about $212,113,000. Charles Schwab Investment Management Inc. grew its holdings in Molina Healthcare by 0.8% during the second quarter. Charles Schwab Investment Management Inc. now owns 419,457 shares of the company’s stock worth $124,956,000 after acquiring an additional 3,216 shares during the period. Finally, Bank of New York Mellon Corp raised its position in Molina Healthcare by 8.5% during the second quarter. Bank of New York Mellon Corp now owns 364,716 shares of the company’s stock valued at $108,649,000 after acquiring an additional 28,562 shares in the last quarter. 98.50% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms have commented on MOH. Cantor Fitzgerald lowered their price objective on Molina Healthcare from $180.00 to $144.00 and set a “neutral” rating on the stock in a research report on Monday, February 9th. Weiss Ratings reissued a “sell (d+)” rating on shares of Molina Healthcare in a report on Thursday, January 22nd. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $224.00 price objective on shares of Molina Healthcare in a report on Tuesday, January 6th. Wall Street Zen downgraded shares of Molina Healthcare from a “hold” rating to a “sell” rating in a research report on Saturday, October 25th. Finally, The Goldman Sachs Group dropped their target price on Molina Healthcare from $167.00 to $124.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 11th. Three investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $162.64.

Molina Healthcare Stock Up 0.1%

MOH stock opened at $135.42 on Wednesday. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.97. The firm has a 50-day moving average of $170.25 and a two-hundred day moving average of $169.18. Molina Healthcare, Inc has a 12 month low of $121.06 and a 12 month high of $359.97. The company has a market cap of $6.97 billion, a price-to-earnings ratio of 15.82 and a beta of 0.49.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Thursday, February 5th. The company reported ($2.75) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.43 by ($3.18). Molina Healthcare had a net margin of 1.04% and a return on equity of 13.60%. The company had revenue of $11.38 billion during the quarter, compared to analysts’ expectations of $10.90 billion. During the same quarter last year, the company earned $5.05 earnings per share. Molina Healthcare’s revenue for the quarter was up 8.3% on a year-over-year basis. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, analysts forecast that Molina Healthcare, Inc will post 24.4 earnings per share for the current fiscal year.

Insider Activity at Molina Healthcare

In related news, Director Richard M. Schapiro sold 357 shares of the company’s stock in a transaction dated Monday, November 24th. The shares were sold at an average price of $143.02, for a total value of $51,058.14. Following the completion of the sale, the director owned 11,352 shares of the company’s stock, valued at approximately $1,623,563.04. This represents a 3.05% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. 1.26% of the stock is currently owned by corporate insiders.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.